Mian Zu

935 total citations · 1 hit paper
15 papers, 792 citations indexed

About

Mian Zu is a scholar working on Epidemiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Mian Zu has authored 15 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Mian Zu's work include Influenza Virus Research Studies (3 papers), Computational Drug Discovery Methods (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Mian Zu is often cited by papers focused on Influenza Virus Research Studies (3 papers), Computational Drug Discovery Methods (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Mian Zu collaborates with scholars based in China, United States and Czechia. Mian Zu's co-authors include Guanhua Du, Liang Yan, Zhanjun Gu, Wenyan Yin, Xiaju Cheng, Cuicui Ge, Dongliang Wang, Yuan Yong, Tao Bao and Yuliang Zhao and has published in prestigious journals such as ACS Nano, Molecules and European Journal of Pharmacology.

In The Last Decade

Mian Zu

14 papers receiving 775 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tungsten Sulfide Quantum Dots as Multifunctional Nanotheranostics for In Vivo Dual-Modal Image-Guided Photothermal/Radiotherapy Synergistic Therapy

2015 381 citations Yuan Yong, Xiaju Cheng et al. ACS Nano profile →

Peers

Countries citing papers authored by Mian Zu

Since Specialization

Citations

This map shows the geographic impact of Mian Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mian Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mian Zu more than expected).

Fields of papers citing papers by Mian Zu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mian Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mian Zu. The network helps show where Mian Zu may publish in the future.

Co-authorship network of co-authors of Mian Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Mian Zu. A scholar is included among the top collaborators of Mian Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mian Zu. Mian Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Radiation emergency medical countermeasures: Current formulary, identified gaps, and future approaches 2025 ·Animal Models and Experimental Medicine ·(unknown), Rong‐Hua Yin, (unknown), Yin Zhang⋆, Lijuan Li, Wei Liu, Ting Chen, Wei Zhou, Mian Zu, Rulan Yin, Xuliang Shi, Lei Wang, Xiaoming Yang	0
2	SCN11A gene deletion causes sensorineural hearing loss by impairing the ribbon synapses and auditory nerves 2021 ·BMC Neuroscience ·Mian Zu, (unknown), Cong Tao, Fei Ji, (unknown), Yue Zhang, Xin Song, Wei Sun, David Z. Z. He, (unknown), (unknown)	4
3	Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines 2018 ·BMC Complementary and Alternative Medicine ·Jiawei Liu, Mian Zu, (unknown), (unknown), Huan Min, (unknown), Weiwen Chen, Ailin Liu	24
4	Rapid analysis of neomycin in cochlear perilymph of guinea pigs using disposable SPE cartridges and high performance liquid chromatography-tandem mass spectrometry 2018 ·Journal of Chromatography B ·Mian Zu, (unknown), (unknown), Shi‐Li Zhang, Yan Yan, (unknown), (unknown), (unknown), Yue Zhang, Weiwei Guo, (unknown)	12
5	Small size fullerenol nanoparticles inhibit thrombosis and blood coagulation through inhibiting activities of thrombin and FXa 2018 ·Nanomedicine Nanotechnology Biology and Medicine ·Shibo Xia, Juan Li, Mian Zu, Jinxia Li, (unknown), Xue Bai, Yanan Chang, Kui Chen, Weihong Gu, Li Zeng, Lina Zhao, (unknown), Gengmei Xing	23
6	<I>In Vivo</I> Toxicity Evaluation of Graphene Oxide in <I>Drosophila Melanogaster</I> After Oral Administration 2016 ·Journal of Nanoscience and Nanotechnology ·Haiyan Zou, Feng Zhao, Weifeng Zhu, Liang Yan, Hanqing Chen, Zhanjun Gu, Qing Yuan, Mian Zu, (unknown), Hongning Liu	4
7	Antidiabetic Effect of Salvianolic Acid A on Diabetic Animal Models via AMPK Activation and Mitochondrial Regulation 2015 ·Cellular Physiology and Biochemistry ·Guifen Qiang, Xiuying Yang, Lili Shi, Hengai Zhang, (unknown), Yan Zhao, Mian Zu, Dan Zhou, Jing Guo, Haiguang Yang, Li Zhang, Guanhua Du	70
8	Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment 2015 ·Molecules ·Mian Zu, Chao Li, Jiansong Fang, Wenwen Lian, Ailin Liu, Lishu Zheng, Guanhua Du	25
9	Tungsten Sulfide Quantum Dots as Multifunctional Nanotheranostics for In Vivo Dual-Modal Image-Guided Photothermal/Radiotherapy Synergistic Therapy breakdown → 2015 ·ACS Nano ·Yuan Yong, Xiaju Cheng, Tao Bao, Mian Zu, Liang Yan, Wenyan Yin, Cuicui Ge, Dongliang Wang, Zhanjun Gu, Yuliang Zhao	381
10	Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels 2014 ·Disease Markers ·Ruihua Cao, Yongyi Bai, Lan Sun, Jin Zheng, Mian Zu, Guanhua Du, Ping Ye	9
11	Salvianolic Acid A Prevents the Pathological Progression of Hepatic Fibrosis in High-Fat Diet-Fed and Streptozotocin-Induced Diabetic Rats 2014 ·The American Journal of Chinese Medicine ·Guifen Qiang, Xiuying Yang, Xuan Qi, Lili Shi, Hengai Zhang, (unknown), Xiaoxiu Li, Mian Zu, Dan Zhou, Jing Guo, Haiguang Yang, Li Zhang, Guanhua Du	43
12	In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives 2012 ·Antiviral Research ·Mian Zu, Fan Yang, (unknown), Ailin Liu, Guanhua Du, Lishu Zheng	116
13	Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes 2012 ·European Journal of Pharmacology ·Guifen Qiang, Li Zhang, Xiuying Yang, Xuan Qi, Lili Shi, Hengai Zhang, (unknown), Xiaoxiu Li, Mian Zu, Dan Zhou, Jing Guo, Haiguang Yang, Guanhua Du	37
14	3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Mian Zu, Song Wu, Ailin Liu, Guanhua Du	31
15	[Evaluation of Chinese traditional patent medicines against influenza virus in vitro]. 2010 ·PubMed ·Mian Zu, (unknown), Li Gao, Ailin Liu, Guanhua Du	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact